87 related articles for article (PubMed ID: 6126367)
21. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
Lau YS; Runice C
Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
[TBL] [Abstract][Full Text] [Related]
22. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
[TBL] [Abstract][Full Text] [Related]
23. Interaction of flunarizine with dopamine D2 and D1 receptors.
Ambrosio C; Stefanini E
Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
[TBL] [Abstract][Full Text] [Related]
24. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
Terai M; Hidaka K; Nakamura Y
Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
[TBL] [Abstract][Full Text] [Related]
25. Effects of radioligand oxidation and ascorbate-induced lipid peroxidation on serotonin-1 receptor assay: use of ascorbate and ethylenediamine tetraacetic acid buffers to prevent (3H)-5-HT binding artifacts.
May PC; Morgan DG; Salo D; Goss JR; Finch CE
J Neurosci Res; 1988; 20(2):257-62. PubMed ID: 3139891
[TBL] [Abstract][Full Text] [Related]
26. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
27. Ascorbate-induced lipid peroxidation and inhibition of [3H]spiroperidol binding in neostriatal membrane preparations.
Heikkila RE; Cabbat FS
J Neurochem; 1983 Nov; 41(5):1384-92. PubMed ID: 6619873
[TBL] [Abstract][Full Text] [Related]
28. Dietary ascorbic acid deficiency in guinea pigs: no effect on ethanol preference, spiroperidol binding, or monoamine oxidase activity.
Dolinsky ZS; Shaskan EG
Life Sci; 1984 May; 34(22):2159-64. PubMed ID: 6727556
[TBL] [Abstract][Full Text] [Related]
29. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
30. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
Chugani DC; Ackermann RF; Phelps ME
J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
[TBL] [Abstract][Full Text] [Related]
31. Ascorbic acid, redox cycling, lipid peroxidation, and the binding of dopamine receptor antagonists.
Heikkila RE; Manzino L
Ann N Y Acad Sci; 1987; 498():63-76. PubMed ID: 3476003
[No Abstract] [Full Text] [Related]
32. Characterization of solubilized dopamine receptors from dog striatum.
Gorissen H; Aerts G; Laduron P
FEBS Lett; 1979 Apr; 100(2):281-5. PubMed ID: 37113
[No Abstract] [Full Text] [Related]
33. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
Nakajima T; Iwata K
Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
[TBL] [Abstract][Full Text] [Related]
34. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
[TBL] [Abstract][Full Text] [Related]
35. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
[TBL] [Abstract][Full Text] [Related]
36. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum.
MacKenzie RG; Zigmond MJ
Eur J Pharmacol; 1985 Jul; 113(2):159-65. PubMed ID: 2864265
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
38. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
Niznik HB; Grigoriadis DE; Seeman P
FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
[TBL] [Abstract][Full Text] [Related]
39. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
[TBL] [Abstract][Full Text] [Related]
40. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
